Atorvastatin + Ezetimibe Tablet Franchise in Ahmedabad

Cholesterol Control Tablet Supplier in Mumbai

Lipid Lowering Tablet Distributor in Delhi

Cardiac Care PCD Pharma Franchise in Bangalore

Atorvastatin Ezetimibe Tablet Stockist in Hyderabad
Cardiology Tablet Manufacturer & Exporter in Chandigarh

Home/Products /atorvastatin-40-mg-ezetimibe-10-mg

Atorable EZ 40 Tablet

Composition : Atorvastatin (40mg) + Ezetimibe (10mg) Tablet

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹0/-

Please Contact For Best Price

Atorable EZ 40 Tablet contains Atorvastatin 40mg + Ezetimibe 10mg, a high-strength dual-action combination used for effective management of high cholesterol and mixed dyslipidemia. It helps in significantly lowering LDL cholesterol and triglycerides, while improving HDL levels, thereby reducing cardiovascular risk.

Atorvastatin works by blocking cholesterol synthesis in the liver, while Ezetimibe inhibits intestinal cholesterol absorption. This dual mechanism provides enhanced lipid-lowering efficacy compared to monotherapy, making it suitable for patients with difficult-to-control cholesterol levels.

This tablet is commonly prescribed for patients requiring more intensive lipid-lowering therapy, particularly those at high risk for cardiovascular events. Its once-daily oral dosage ensures convenient administration and improved compliance for long-term therapy.

For PCD pharma franchise partners, Atorable EZ 40 Tablet is a high-demand cardiac care product, available at the best price for PCD pharma franchise. Its clinical reliability, strong prescriber trust, and steady market demand make it a valuable addition to any cardiology or lipid-lowering product portfolio.


Read More

About the Product

Atorable EZ 40 Tablet contains Atorvastatin 40mg + Ezetimibe 10mg, a high-strength dual-action combination used for effective management of high cholesterol and mixed dyslipidemia. It helps in significantly lowering LDL cholesterol and triglycerides, while improving HDL levels, thereby reducing cardiovascular risk.

Atorvastatin works by blocking cholesterol synthesis in the liver, while Ezetimibe inhibits intestinal cholesterol absorption. This dual mechanism provides enhanced lipid-lowering efficacy compared to monotherapy, making it suitable for patients with difficult-to-control cholesterol levels.

This tablet is commonly prescribed for patients requiring more intensive lipid-lowering therapy, particularly those at high risk for cardiovascular events. Its once-daily oral dosage ensures convenient administration and improved compliance for long-term therapy.

For PCD pharma franchise partners, Atorable EZ 40 Tablet is a high-demand cardiac care product, available at the best price for PCD pharma franchise. Its clinical reliability, strong prescriber trust, and steady market demand make it a valuable addition to any cardiology or lipid-lowering product portfolio.


Common side effects may include headache, muscle pain, abdominal discomfort, nausea, or diarrhea. Rare but serious effects include liver enzyme elevation, myopathy or rhabdomyolysis, and severe allergic reactions. Any unexplained muscle pain or weakness should be promptly reported to a healthcare professional.

Atorable EZ 40 Tablet is indicated for the treatment of hypercholesterolemia, mixed dyslipidemia, and elevated LDL cholesterol, and for reducing the risk of cardiovascular events in patients with coronary artery disease or at high cardiovascular risk.

Take Atorable EZ 40 Tablet exactly as prescribed, usually once daily, with or without food. Regular monitoring of lipid profile and liver function tests is recommended. Patients with liver disease, a history of muscle disorders, or who consume excessive alcohol should exercise caution.

Store Atorable EZ 40 Tablet in a cool, dry place, protected from direct sunlight and moisture. Keep out of reach of children and do not use after the expiry date indicated on the packaging.

Get in Touch